Advertisement
The Medicine Maker / Issues / 2017 / Nov / Formulating the Future
Business & Regulation Formulation Business & Trends

Formulating the Future

A Spotlight Interview with... Kishor Wasan, Dean of the College of Pharmacy and Nutrition, University of Saskatchewan, Canada.

11/27/2017 1 min read

Share

References

  1. KM Wasan et al., “Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery”, Nat Rev Drug Discov, 7, 84-99 (2008). PMID: 18079757
Advertisement

Recommended

Advertisement

Related Content

The Confidentiality Barrier to AI-Enabled Drug Development
Small Molecules Small Molecules Formulation
The Confidentiality Barrier to AI-Enabled Drug Development

July 27, 2026

3 min read

AI can help formulation teams better predict performance and allocate resources, but proprietary data protections remain a critical bottleneck

Why Drug Development Still Lacks Integration
Small Molecules Small Molecules Business & Trends
Why Drug Development Still Lacks Integration

July 21, 2026

4 min read

John McDermott reflects on why early drug development remains fragmented – and how integrated approaches may shorten timelines

In Vivo CAR T: A New Route to Treating Autoimmune Disease
Cell & Gene Drug Delivery Development & Clinical
In Vivo CAR T: A New Route to Treating Autoimmune Disease

July 13, 2026

6 min read

How targeted in vivo CAR T delivery could pave the way for autoimmune disease treatments

Reformulating the Future of Small Molecules
Small Molecules Drug Discovery Formulation
Reformulating the Future of Small Molecules

June 30, 2026

1 min read

A special collection of recent stories exploring oral dose innovation, API stability, nitrosamine testing, and the evolving science of small molecule medicines

Advertisement